Continuous glucose monitoring during intravenous insulin infusion treatment: Assessing accuracy to enable future clinical utility
Open Access
- 21 May 2025
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 42 (9) , e70076
Abstract
Aims: Continuous glucose monitoring (CGM) during intravenous insulin infusions (IVII) could reduce blood glucose (BG) testing burden in hospital, however CGM accuracy concerns exist. We aimed to assess CGM accuracy during IVII.Methods: This multi‐centre observational study included adults with type 1 diabetes (T1D) who required IVII treatment during hospital admission whilst wearing their own CGM devices (Abbott FreeStyle Libre 2, Medtronic Guardian 3, Dexcom G6). IVII dose adjustments were performed based upon standard of care BG measures. Accuracy was assessed according to mean absolute relative difference (MARD) and Consensus error grid (CEG) analysis, using time‐matched (±5 minutes) pairs of CGM glucose and reference BG (point‐of‐care [POC], blood gas [GAS]) obtained during IVII.Results: In total, 736 time‐matched glucose pairs were obtained from 56 hospital admissions (52% with diabetic ketoacidosis; 32% requiring intensive care). Median IVII duration was 16 hours (IQR 7.2–28). Overall MARD was 12.5% (11.9% for CGM‐POC pairs; 14.1% for CGM‐GAS pairs). In CEG analysis, 99.0% of glucose pairs were within zones A/B. Based on local hospital IVII dose titration protocols for non‐intensive care wards, if CGM measures had been used instead of POC, dose adjustments would have been the same in 77% of instances.Conclusions: This real‐world study of adults with T1D demonstrated high concordance of CGM measures with BG during IVII. The accuracy of CGM during IVII might enable its greater clinical utility when treating inpatients receiving IVII. More inpatient studies are required to validate the use of CGM during IVII.Keywords
Funding Information
- Australian Government
- University of Melbourne
This publication has 23 references indexed in Scilit:
- Accuracy of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Admitted to Hospital: A Real-World Multicenter Observational StudyDiabetes Technology & Therapeutics, 2025
- Continuous Glucose Monitoring for Patients with COVID-19 Pneumonia: Initial Experience at a Tertiary Care CenterEndocrine Practice, 2022
- Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective StudyJournal of Diabetes Science and Technology, 2022
- Reliability of Inpatient CGM: Comparison to Standard of CareJournal of Diabetes Science and Technology, 2021
- Longitudinal prevalence of inpatient diabetes mellitus in an Australian hospital across five decades: 1972–2019Internal Medicine Journal, 2021
- Hospital care: improving outcomes in type 1 diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2020
- Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trialCritical Care, 2014
- Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Measuring agreement in method comparison studiesStatistical Methods in Medical Research, 1999
- Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical proceduresThe Annals of Thoracic Surgery, 1999